Renalytix Share Discussion Threads

[golfnut59] 23/4/2021 13:05

hpcg, thanks for your reply. Unfortunately the JP Morgan presentation has been removed by JP Morgan so its no longer available to view.

[hpcg] 23/4/2021 12:56

golfnut - go back on this board to the beginning of this year and find the link to the JP Morgan conference presentation. This has all the answers you need. FDA is really about Medicare co-pay. Also if you are not familiar with how US health industry functions then find out about that for you own education. The whole mesh of physicians, insurers and providers is very complicated. I lived there for a few years and I still don't really understand it all.

[golfnut59] 23/4/2021 12:40

Hi,
I'm new to RENX. After reading yesterdays RNS on the big US Government contract win I immediately starting researching this company. I'm a bit confused as to the state of play with the FDA and what exactly the MCIT ruling implies. Do the company already have clearance to sell the tests from the FDA? If not, when are we likely to hear from the FDA on this? I'm a bit confused as I read that the test had already been given clearance from the FDA's via their "Designated Breakthrough Devices" route. Also, what is the Medicare/MCIT ruling all about and how does it impact on RENX? Sorry for the newbie questions, and thanks in advance to anyone who can help me out with this.

[lottsgold] 23/4/2021 10:12

I thought the US investors would see the opportunity more than over here. Seems totally overlooked still, maybe some write ups over the weekend in the US could stir it up

[wan] 23/4/2021 08:25

I think some where confused by the fact that there are two ADS for each UK share, but sometimes there is perhaps a catch-up element (one way or the other).

[ramridge] 23/4/2021 08:18

If you overlay the share price chart of RENX (UK) to RNLX (US) over say the last 12 months, you will see a near identical match.
What does it mean? Well there is no point in looking at the US for any lead or pointers. They are in sync and that's it.

[hpcg] 22/4/2021 15:30

I thought the prior RNS was as important. Demonstrated efficacy saving both money and patient health makes it an easy sell; 950 bucks is nothing for a US health plan. The orders will follow. Today accelerates the distribution which is great for the DCF but less important than the portfolio of efficacy data in the long term in my opinion.

[babbler] 22/4/2021 14:49

Thanks. Long term irrelevant as this will do very well..

[74tom] 22/4/2021 14:46

Babbler, the UK is not behind. The US is trading at $31 ish right now, there are 2 ADS for each UK ordinary share, so it's $15.5 for comparison. Current FX rate is 1.385, so $15.5 = £11.19. The US listing actually closed down around 5% last night which is why it's up further in % terms.

[mr roper] 22/4/2021 14:44

Still early. The next few weeks we’ll get a better of idea of where this is going. Hopefully this gets us on a few bigger investor radars. Fda approval with mcit would be the cherry on top.

[babbler] 22/4/2021 14:42

Maybe shoulda traded USA one then... UK one is behind and not moving... :/

[mr roper] 22/4/2021 14:38

$rnlx should see 1m Plus in vol today. 400k traded already

[babbler] 22/4/2021 14:38

USA open and running 24%. UK not doing much.

[babbler] 22/4/2021 13:53

But it hit 31 dollars... Hmmm.

[74tom] 22/4/2021 13:39

Walbrook PR tweet about an hour ago;

Stifel reiterates its BUY rating for Renalytix following the 10-year US Government contract @RenalytixAI #RENX @Stifel
- it opens the door to the servicing of ~1 million eligible patients tied to gov't physicians, which should meaningfully aid the overall testing ramp. TP $30"

Stifel had a previous TP of $22, so this is a significant upgrade although still pretty low ball (presumably because we haven't recorded material revenues yet...).

[mr roper] 22/4/2021 13:14

$rnlx up 25% so far in the pre market. Could get lively.

[mr roper] 22/4/2021 13:07

Once $rnlx clears $31 it’s blue sky territory. I think $90 is pretty achievable in the short to mid term

[frazboy] 22/4/2021 13:05

Looks to be heading north on NASDAQ pre-open. Watching with interest.

[babbler] 22/4/2021 12:51

Lunch dip buy op.

[74tom] 22/4/2021 12:37

Would like to see NASDAQ volume exceed the 1m mark today, that's what we need to start and generate real price movement here.

[someuwin] 22/4/2021 12:19

Moving on Nasdaq pre-open

NASDAQ:RNLX

[intrinsicinvestor] 22/4/2021 12:18

Hi, any price target given?Thanks

[mr roper] 22/4/2021 11:09

Investec upgrade to Buy from Hold

[mr roper] 22/4/2021 11:04

It’s a monstrous contract on any metric. The Yanks have got to love this.